All-Stars Investment LTD Stake In Alibaba Group Hldg LTD (BABA) Was Increased; Chemocentryx (CCXI) Holder Millennium Management Has Cut Position by $1.81 Million

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Millennium Management Llc decreased its stake in Chemocentryx Inc (CCXI) by 91.5% based on its latest 2018Q4 regulatory filing with the SEC. Millennium Management Llc sold 181,037 shares as the company’s stock rose 6.99% with the market. The hedge fund held 16,813 shares of the health care company at the end of 2018Q4, valued at $183,000, down from 197,850 at the end of the previous reported quarter. Millennium Management Llc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $708.77M market cap company. The stock increased 2.26% or $0.27 during the last trading session, reaching $12.21. About 202,567 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 15, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress

All-Stars Investment Ltd increased its stake in Alibaba Group Hldg Ltd (BABA) by 563.22% based on its latest 2018Q4 regulatory filing with the SEC. All-Stars Investment Ltd bought 98,000 shares as the company’s stock rose 17.52% with the market. The institutional investor held 115,400 shares of the business services company at the end of 2018Q4, valued at $15.82M, up from 17,400 at the end of the previous reported quarter. All-Stars Investment Ltd who had been investing in Alibaba Group Hldg Ltd for a number of months, seems to be bullish on the $464.99 billion market cap company. The stock increased 2.60% or $4.54 during the last trading session, reaching $179.38. About 28.16 million shares traded or 111.92% up from the average. Alibaba Group Holding Limited (NYSE:BABA) has risen 2.89% since May 15, 2018 and is uptrending. It has underperformed by 1.48% the S&P500. Some Historical BABA News: 16/05/2018 – MEDIA-Ant Financial claims a rise in user numbers to 622 mln – FT; 13/04/2018 – ALIBABA PICTURES GROUP LTD SEES NET LOSS ATTRIBUTABLE FOR 15 MTHS ENDED MARCH 31, 2018 BETWEEN RMB1.6 BLN AND RMB1.7 BLN; 06/04/2018 – SoftBank borrows $8 billion using its Alibaba stake – Bbg; 15/05/2018 – Barclays Adds Aptiv, Cuts Alibaba: 13F; 30/04/2018 – TRADE WAR CONSEQUENCES ‘WILL BE QUITE SEVERE,’ SAYS BABA’S TSAI; 03/05/2018 – Alibaba is ‘Fundamentally Strong,’ Activate’s Michael Wolf Says (Video); 23/05/2018 – China’s first private credit-scoring firm starts operations-Xinhua; 19/03/2018 – Alibaba to invest additional $2bn in Lazada, replaces CEO; 29/05/2018 – Alibaba Group Holding: ZTO Investment to Tap New Retail Opportunities and Further Digitalize China’s Logistics Industry; 29/05/2018 – Alibaba, Cainiao Lead $1.4 Billion Spend on Delivery-Firm Stake

More notable recent Alibaba Group Holding Limited (NYSE:BABA) news were published by: 247Wallst.com which released: “Alibaba Earnings: What Trade Talks? – 24/7 Wall St.” on May 15, 2019, also Benzinga.com with their article: “8 Stocks To Watch For May 15, 2019 – Benzinga” published on May 15, 2019, Seekingalpha.com published: “Alibaba: Assessing The Relative Valuation – Seeking Alpha” on April 24, 2019. More interesting news about Alibaba Group Holding Limited (NYSE:BABA) were released by: Benzinga.com and their article: “Earnings Scheduled For May 15, 2019 – Benzinga” published on May 15, 2019 as well as Seekingalpha.com‘s news article titled: “Tencent-backed game streamer DouYu files for U.S. IPO – Seeking Alpha” with publication date: April 23, 2019.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” on September 28, 2018, also Seekingalpha.com with their article: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” published on March 12, 2019, Nasdaq.com published: “ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates – Nasdaq” on May 06, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” published on May 06, 2019 as well as Globenewswire.com‘s news article titled: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” with publication date: April 16, 2019.

Since January 7, 2019, it had 0 insider purchases, and 5 insider sales for $1.38 million activity. $447,092 worth of stock was sold by Schall Thomas J. on Thursday, January 10. Shares for $457,747 were sold by KANAYA SUSAN M.

Millennium Management Llc, which manages about $64.13 billion US Long portfolio, upped its stake in New Residential Invt Corp (NYSE:NRZ) by 390,863 shares to 1.09 million shares, valued at $15.43M in 2018Q4, according to the filing. It also increased its holding in Vistra Energy Corp by 3.38 million shares in the quarter, for a total of 3.40 million shares, and has risen its stake in Thor Inds Inc (NYSE:THO).

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *